Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: January 26, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Cannabinol

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Cannabinol?

Cannabinol is an investigational drug.

There have been 38 clinical trials for Cannabinol. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2009.

The most common disease conditions in clinical trials are Marijuana Abuse, Chronic Pain, and Nausea. The leading clinical trial sponsors are Radboud University, Yale University, and Central Institute of Mental Health, Mannheim.

Recent Clinical Trials for Cannabinol
Safety and Effects on Responses to Stress and Pain of Natural Medical Marijuana ProductsConnecticut Pharmaceutical SolutionsPhase 1
Safety and Effects on Responses to Stress and Pain of Natural Medical Marijuana ProductsYale UniversityPhase 1
Cannabis For Cancer-Related SymptomsPippa HawleyPhase 2

See all Cannabinol clinical trials

Clinical Trial Summary for Cannabinol

Top disease conditions for Cannabinol
Top clinical trial sponsors for Cannabinol

See all Cannabinol clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.